New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
Actuate Therapeutics, Inc. (ACTU) vs Neuphoria Therapeutics Inc. (NEUP)
- Actuate Therapeutics, Inc. ACTU 0.23 +9.52%
- Neuphoria Therapeutics Inc. NEUP 2.35 +1.29%
Actuate Therapeutics, Inc. and Neuphoria Therapeutics Inc. are both Biotechnology companies. Actuate Therapeutics, Inc. and Neuphoria Therapeutics Inc. are of similar size ($12.9M and $12.6M). Across the 8 metrics below, Neuphoria Therapeutics Inc. leads on 5 and Actuate Therapeutics, Inc. on 3.
Valuation
Profitability
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack